Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NOBEX Corporation

!S!WCRTESTINPUT000000!E!

Latest From NOBEX Corporation

Titans Of Pharma: J&J Back On Top For CEO Remuneration

J&J topped the league table for CEO pay in 2023, a position it has held for three of the four past years. Meanwhile, the two companies that arguably generated the most buzz in 2023 neatly depict the stark contrast between the US and Europe when it comes to executive remuneration.

Sales & Earnings Business Strategies

US Consumer Health Q2 Earnings Preview: If Not For Headwinds, Tailwinds Would Be Trending

Analysts tracking consumer health product firms in the US anticipatevApril-June results lower than a year ago across most businesses. While some results will be lower on comparisons with strong growth in 2023, others will reflect a slow allergy season, retailers’ inventories remaining high as consumer spending slows or firms continuing to recover from supply chain problems.

Consumer Business Strategies

Another Expert Fails Judge’s Review In Litigation Challenging OTC Acetaminophen Safety

Kenvue plans to ask judge to dismiss complaints relying on testimony from latest expert plaintiffs’ attorneys offered that prenatal use of Tylenol or other acetaminophen oral products is linked autism and ADHD in children. Judge previously dismissed complaints relying on five other experts’ testimony.

Litigation OTC Drugs

How The IRA Factored Into Akebia’s Price For Vafseo

Akebia says its price for Vafseo at about $15,500 per year, meant to reflect its potential value in dialysis as well as eventually in non-dialysis patients.

Medicare Renal
See All

Company Information

UsernamePublicRestriction

Register